Wednesday, August 10, 2022


Biotechnology News Magazine


New Study Highlights Superior Efficacy of At-home Dry EEG assessment Compared to Lab-based Monitoring

Results indicate that easy-to-use task-driven EEG can yield clinical-grade data in large-scale, real-world investigations in neuroscience with extremely high adherence rates.

Bio-Teche Corporation Announces CEO Transition Plan

Bio-Teche notes Chuck Kummeth's planned two-year transition from his position as Bio-Techne's CEO becomes effective June 30, 2024.

ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement

License allows Lepton Pharmaceuticals with their proprietary Castling Technology, to develop and commercialize products and services using CRISPR/Cas9 technology.

FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory

Heavy Oil for Embryo Culture is approved for sale immediately in the USA, Japan, Korea, and Hong Kong.

TransCure bioServices Welcomes Cathay Capital to Accelerate its Ambitious Growth

TransCure bioServices has developed an unrivalled quality of services for a large and international customer base, providing c.70 large pharmas and biotech companies with a full spectrum of analytical testing services.

Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Cancer

Evaxion Biotech currently have two product candidates in their DNA technology platform, EVX-02, and EVX-03. Based on very encouraging results from their pre-clinical studies of EVX-03, the company decided to use this candidate in an upcoming clinical trial in a new indication.